250.41
price down icon1.07%   -2.70
after-market  After Hours:  251.75  1.34   +0.54%
loading
Danaher Corp. stock is currently priced at $250.41, with a 24-hour trading volume of 3.09M. It has seen a -1.07% decreased in the last 24 hours and a -1.72% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $253.1 pivot point. If it approaches the $249.6 support level, significant changes may occur.
Previous Close:
$253.11
Open:
$249.03
24h Volume:
3.09M
Market Cap:
$185.48B
Revenue:
$23.89B
Net Income/Loss:
$4.76B
P/E Ratio:
31.58
EPS:
7.93
Net Cash Flow:
$5.78B
1W Performance:
+4.60%
1M Performance:
-1.72%
6M Performance:
+27.21%
1Y Performance:
-1.55%
1D Range:
Value
$247.98
$254.09
52W Range:
Value
$182.09
$269.61

Danaher Corp. Stock (DHR) Company Profile

Name
Name
Danaher Corp.
Name
Phone
202-828-0850
Name
Address
2200 Pennsylvania Avenue NW, Suite 800W, Washington, DC
Name
Employee
67,000
Name
Twitter
@Danaher_U
Name
Next Earnings Date
2024-04-23
Name
Latest SEC Filings
Name
DHR's Discussions on Twitter

Danaher Corp. Stock (DHR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-24-24 Downgrade Barclays Overweight → Equal Weight
Dec-18-23 Initiated HSBC Securities Hold
Dec-13-23 Resumed Wolfe Research Peer Perform
Dec-07-23 Downgrade Goldman Buy → Neutral
Jul-19-23 Initiated Raymond James Outperform
May-01-23 Initiated SVB Securities Outperform
Apr-26-23 Downgrade BofA Securities Buy → Neutral
Apr-18-23 Upgrade Wells Fargo Equal Weight → Overweight
Jan-05-23 Downgrade Credit Suisse Outperform → Neutral
Dec-14-22 Initiated Deutsche Bank Buy
Oct-24-22 Downgrade The Benchmark Company Buy → Hold
Aug-25-22 Initiated Credit Suisse Outperform
Aug-17-22 Resumed Bernstein Outperform
Jul-20-22 Initiated UBS Buy
Jun-01-22 Upgrade RBC Capital Mkts Sector Perform → Outperform
Apr-25-22 Downgrade Wells Fargo Overweight → Equal Weight
Jan-11-22 Initiated Bernstein Outperform
Oct-15-21 Resumed Cowen Outperform
Sep-10-21 Reiterated BofA Securities Buy
Aug-05-21 Resumed Credit Suisse Outperform
Jul-23-21 Reiterated Goldman Buy
Jul-16-21 Initiated The Benchmark Company Buy
Apr-07-21 Resumed Robert W. Baird Outperform
Mar-03-21 Resumed Barclays Overweight
Dec-02-20 Initiated Goldman Buy
Nov-25-20 Downgrade RBC Capital Mkts Outperform → Sector Perform
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Jun-16-20 Upgrade Wolfe Research Peer Perform → Outperform
Apr-02-20 Downgrade Wolfe Research Outperform → Peer Perform
Mar-26-20 Upgrade RBC Capital Mkts Sector Perform → Outperform
Feb-03-20 Reiterated Needham Buy
Jan-08-20 Initiated Wells Fargo Overweight
Jan-07-20 Initiated Citigroup Buy
Nov-15-19 Resumed Stifel Hold
Oct-28-19 Reiterated Needham Buy
Oct-14-19 Resumed Credit Suisse Outperform
Jul-19-19 Reiterated Needham Buy
Jun-11-19 Initiated Piper Jaffray Neutral
May-30-19 Initiated Wolfe Research Outperform
Apr-17-19 Reiterated Needham Buy
Feb-28-19 Reiterated Needham Buy
Feb-25-19 Upgrade Janney Neutral → Buy
Jan-03-19 Initiated Needham Buy
Apr-20-18 Reiterated Stifel Buy
View All

Danaher Corp. Stock (DHR) Financials Data

Danaher Corp. (DHR) Revenue 2024

DHR reported a revenue (TTM) of $23.89 billion for the quarter ending December 31, 2023, a -10.33% decline year-over-year.
loading

Danaher Corp. (DHR) Net Income 2024

DHR net income (TTM) was $4.76 billion for the quarter ending December 31, 2023, a -33.92% decrease year-over-year.
loading

Danaher Corp. (DHR) Cash Flow 2024

DHR recorded a free cash flow (TTM) of $5.78 billion for the quarter ending December 31, 2023, a -21.89% decrease year-over-year.
loading

Danaher Corp. (DHR) Earnings per Share 2024

DHR earnings per share (TTM) was $6.39 for the quarter ending December 31, 2023, a -33.78% decline year-over-year.
loading

Danaher Corp. Stock (DHR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Raskas Daniel
SVP - Corporate Development
Feb 26 '24
Option Exercise
58.48
23,757
1,389,309
61,859
Raskas Daniel
SVP - Corporate Development
Feb 26 '24
Sale
252.00
23,757
5,986,764
38,102
LOHR WALTER G
Director
Feb 15 '24
Option Exercise
52.56
3,289
172,870
17,418
LOHR WALTER G
Director
Feb 15 '24
Sale
251.15
3,289
826,032
14,129
Couchara Georgeann
SVP, Human Resources
Feb 13 '24
Option Exercise
70.71
2,622
185,414
6,022
Couchara Georgeann
SVP, Human Resources
Feb 13 '24
Sale
242.67
2,622
636,290
4,244
List Teri
Director
Feb 06 '24
Option Exercise
52.56
3,289
172,870
23,015
List Teri
Director
Feb 06 '24
Sale
248.32
3,289
816,724
19,726
Gutierrez-Ramos Jose-Carlos
SVP, Chief Science Officer
Aug 21 '23
Sale
250.54
590
147,819
6,939
Raskas Daniel
SVP - Corporate Development
Jul 28 '23
Option Exercise
56.70
11,213
635,777
49,501
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
diagnostics_research TMO
$577.39
price up icon 0.49%
diagnostics_research IQV
$240.84
price up icon 0.93%
$494.26
price up icon 0.09%
diagnostics_research A
$137.49
price down icon 1.23%
diagnostics_research MTD
$1,235.37
price down icon 0.48%
Cap:     |  Volume (24h):